About Actgen Pharma Private Limited
Data last updated: 01 January 2026
Actgen Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 08 March 2008, the company has been in operation for over 18 years.
Registered with ROC Mumbai under CIN U24239MH2008PTC179859.
Capital: an authorised share capital of ₹9 Cr and a paid-up capital of ₹9 Cr. It is led by directors Kantilal Mangalchand Hiran and Dariyadevi Kantilal Hiran.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Shop No. 45 1St Floor Rustomjee Ease Zone Goregaon Mulund Link Road Malad (West), Mumbai, Maharashtra, India – 400062.
As per the financials filed for FY 2023, the company reported a revenue of ₹10.17 Cr, reflecting significant growth compared to the previous year.
The company is associated with 1 brand - Actgen Pharma. As per MCA filings, the company has satisfied charges of ₹72 Cr on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website actgen.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressShop No. 45 1St Floor Rustomjee Ease Zone Goregaon Mulund Link Road Malad (West), Mumbai, Maharashtra, India – 400062
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Actgen Pharma Private Limited
Actgen Pharma Private Limited operates one associated brand: ActGen Pharma. These brands represent Actgen Pharma Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures active pharmaceutical ingredients (APIs). | actgen.in |
Competitors & Alternatives of Actgen Pharma Private Limited
Brands and companies operating in the same space as Actgen Pharma Private Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Symbiotec
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
Beijing Biostar Technologies
|
APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China, China | 2002 |
Sterling Pharma Solutions
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
Provepharm Life Solutions
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
Hikal
|
APIs and intermediates are produced via custom synthesis and research. | Mumbai, India, India | 1988 |
Snapdragon Chemistry
|
Drug discovery and development service provider | Cambridge, United States, United States | 2014 |
SeQuent
|
APIs are developed and manufactured for therapeutic areas. | Bengaluru, India, India | 2002 |
Jubilant Pharma
|
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India, India | 1978 |
Business Activity of Actgen Pharma Private Limited
Actgen Pharma Private Limited operates primarily in the manufacturing sector. The company has 2 registered business activity segments, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Locked | Manufacturing | Locked | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| Locked | Manufacturing | Locked | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Detailed business activity records for Actgen Pharma Private Limited
Activity codes and turnover contribution percentages require an active report plan.
- Activity group codes
- Detailed activity codes
- Turnover contribution
Verified entity values are shown only after access is granted.
Auditor Details of Actgen Pharma Private Limited
Actgen Pharma Private Limited is audited by RDJ and Associates LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RDJ and Associates LLP | Locked | Locked | Locked |
Complete auditor history for Actgen Pharma Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Actgen Pharma Private Limited
Actgen Pharma Private Limited is currently managed by 2 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Kantilal Mangalchand Hiran
Also directs:
Sunflower Trading And Investment Pvt Ltd
|
Director | 05 Sep 2023 | 2 Years 11 Months | Current |
| Dariyadevi Kantilal Hiran | Director | 06 Nov 2023 | 2 Years 9 Months | Current |
Financials of Actgen Pharma Private Limited FY 2025 filings available
Actgen Pharma Private Limited reported revenue of ₹10.17 Cr (up 980.20% YoY) for FY 2023.
Ten-year financial statements for Actgen Pharma Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Actgen Pharma Private Limited
Shareholding and ownership data for Actgen Pharma Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Actgen Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jan 2010 | Bank of India | ₹27 Cr | Satisfied |
| 27 Feb 2009 | Bank of India | ₹27 Cr | Satisfied |
| 27 Nov 2008 | Bank of India | ₹18 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Actgen Pharma Private Limited
Actgen Pharma Private Limited has a workforce of 0 employees as of Apr 06, 2024.
Employee and EPFO history for Actgen Pharma Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Actgen Pharma Private Limited
GST registrations and filing compliance for Actgen Pharma Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Actgen Pharma Private Limited
Credit ratings, litigation, and regulatory alerts for Actgen Pharma Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Actgen Pharma Private Limited
MSME payment history for Actgen Pharma Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Actgen Pharma Private Limited
Corporate group structure for Actgen Pharma Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Actgen Pharma Private Limited
MCA filings and documents for Actgen Pharma Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Actgen Pharma Private Limited
Frequently Asked Questions about Actgen Pharma Private Limited
Actgen Pharma Private Limited is an active private limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 08 March 2008 (18+ years old) and is registered under CIN U24239MH2008PTC179859.
Actgen Pharma Private Limited reported revenue of ₹10.17 Cr for FY 2023 (up 980.20% YoY).
The current directors of Actgen Pharma Private Limited are:
- Kantilal Mangalchand Hiran - Director
- Dariyadevi Kantilal Hiran - Director
The primary industry of Actgen Pharma Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Actgen Pharma Private Limited can be reached at the registered office: Shop No. 45 1St Floor Rustomjee Ease Zone Goregaon Mulund Link Road Malad West, Mumbai, Maharashtra, India – 400062, or through the website actgen.in.
The authorised capital is ₹9 Cr, and the paid-up capital is ₹9 Cr.